• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脂降低试验中的血清甘油三酯与临床益处。

Serum triglycerides and clinical benefit in lipid-lowering trials.

作者信息

Kesäniemi Y A

机构信息

Department of Internal Medicine and Biocenter Oulu, University of Oulu, Finland.

出版信息

Am J Cardiol. 1998 Feb 26;81(4A):70B-73B. doi: 10.1016/s0002-9149(98)00042-3.

DOI:10.1016/s0002-9149(98)00042-3
PMID:9526818
Abstract

Trial evidence shows that effective lowering of serum total cholesterol and particularly of low-density lipoprotein (LDL) cholesterol is important for the prevention of total mortality, coronary artery disease mortality, and major coronary events. The role of serum triglyceride reduction in achieving clinical benefit is unclear and poorly documented. On the other hand, no specific trials have studied the importance of triglyceride lowering among patients with marked hypertriglyceridemia. One of the problems in assessing patients with high serum triglyceride levels may be the heterogeneous background of the molecular mechanisms that result in hypertriglyceridemia.

摘要

试验证据表明,有效降低血清总胆固醇,尤其是低密度脂蛋白(LDL)胆固醇,对于预防总死亡率、冠状动脉疾病死亡率和主要冠状动脉事件至关重要。降低血清甘油三酯在实现临床益处方面的作用尚不清楚,且记录不足。另一方面,尚无具体试验研究在明显高甘油三酯血症患者中降低甘油三酯的重要性。评估血清甘油三酯水平高的患者时存在的问题之一可能是导致高甘油三酯血症的分子机制背景存在异质性。

相似文献

1
Serum triglycerides and clinical benefit in lipid-lowering trials.血脂降低试验中的血清甘油三酯与临床益处。
Am J Cardiol. 1998 Feb 26;81(4A):70B-73B. doi: 10.1016/s0002-9149(98)00042-3.
2
Comparison of statins in hypertriglyceridemia.他汀类药物在高甘油三酯血症中的比较。
Am J Cardiol. 1998 Feb 26;81(4A):66B-69B. doi: 10.1016/s0002-9149(98)00041-1.
3
Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.共识声明:“他汀类药物”治疗在高甘油三酯血症患者中的作用
Am J Cardiol. 1998 Feb 26;81(4A):1B-6B. doi: 10.1016/s0002-9149(98)00030-7.
4
Effects of bezafibrate and simvastatin on plasma lipoproteins in hypercholesterolemia resistant to hormone replacement therapy.苯扎贝特和辛伐他汀对激素替代疗法耐药的高胆固醇血症患者血浆脂蛋白的影响。
Maturitas. 2001 May 30;38(3):279-86. doi: 10.1016/s0378-5122(00)00223-1.
5
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.在胆固醇与再发事件试验中,普伐他汀治疗期间血浆低密度脂蛋白浓度与冠状动脉再发事件之间的关系。
Circulation. 1998 Apr 21;97(15):1446-52. doi: 10.1161/01.cir.97.15.1446.
6
Triglyceride as a risk factor for coronary artery disease.甘油三酯作为冠状动脉疾病的一个风险因素。
Am J Cardiol. 1998 Nov 5;82(9A):22Q-25Q. doi: 10.1016/s0002-9149(98)00770-x.
7
Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge? GISSI Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico).低剂量(20毫克)普伐他汀在4271例近期心肌梗死患者中的GISSI预防试验结果:停止的试验对整体知识有贡献吗?GISSI预防研究组(意大利心肌梗死存活研究组)
Ital Heart J. 2000 Dec;1(12):810-20.
8
Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.识别冠心病高危患者:降脂药物治疗试验的启示
QJM. 2000 Sep;93(9):567-74. doi: 10.1093/qjmed/93.9.567.
9
Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes.苯扎贝特和普伐他汀对2型糖尿病患者残留样脂蛋白颗粒及脂蛋白亚类的影响。
Diabetes Res Clin Pract. 2003 Mar;59(3):181-9. doi: 10.1016/s0168-8227(02)00243-7.
10
Comparative study of bezafibrate and pravastatin in patients with coronary artery disease and high levels of remnant lipoprotein.贝扎贝特与普伐他汀在伴有残余脂蛋白的高胆固醇血症的冠心病患者中的对比研究
Circ J. 2010 Aug;74(8):1644-50. doi: 10.1253/circj.cj-10-0079. Epub 2010 Jun 22.

引用本文的文献

1
Triglycerides and coronary risk.甘油三酯与冠心病风险
Curr Cardiol Rep. 1999 Jul;1(2):125-30. doi: 10.1007/s11886-999-0070-4.